Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: A Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation
- André Tichelli*
- , Régis Peffault De Latour
- , Jakob Passweg
- , Cora Knol-Bout
- , Gérard Socié
- , Judith Marsh
- , Hubert Schrezenmeier
- , Britta Höchsmann
- , Andrea Bacigalupo
- , Sujith Samarasinghe
- , Alicia Rovó
- , Austin Kulasekararaj
- , Alexander Röth
- , Dirk Jan Eikema
- , Paul Bosman
- , Peter Bader
- , Antonio Risitano
- , Carlo Dufour
*Corresponding author for this work
- University of Basel Hospital
- Université Paris-Saclay
- European Society for Blood and Marrow Transplantation
- Department of Haematological Medicine
- KCH King's College Hospital NHS Foundation Trust
- Ulm University Medical Centre
- Agostino Gemelli University Polyclinic
- Great Ormond Street Hospital for Children NHS Foundation Trust
- UniversitatsSpital Bern
- University Hospital Essen
- Goethe University Frankfurt Hospital
- University of Naples Federico II
- IRCCS Istituto Giannina Gaslini - Ospedale Pediatrico
Research output: Contribution to journal › Article › peer-review
62
Citations
(Scopus)